Tsutae Den Nagata, MD

Senior Vice President
Shionogi & Co., Ltd.
Osaka, Osaka, Japan

Disclosure: Shionogi & Co., Ltd.: Employee

Presentation(s):

• LB4 - Efficacy and Safety of Cefiderocol versus High-Dose Meropenem in Patients with Nosocomial Pneumonia – Results of a Phase 3 Randomized, Multicenter, Double-Blind, Non-Inferiority Study

  Thursday, October 3
  2:15 PM – 2:25 PM